Methadone treatment for patients who use fentanyl: Recommendations

Guidelines
par
Bromley, Lisa A et al

Date de publication

2021

Géographie

Canada

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

Constatations/points à retenir

This document was initiated to address specific issues related to methadone prescribing, dose titration, and treatment retention in the context of the fentanyl crisis. The recommendations are based on the premise that clinical decisions should have the overarching objective of promoting patient engagement and retention in treatment, as duration of treatment has been shown to be a crucial predictor of outcomes. This is not an exhaustive review of all aspects of methadone prescribing. Although the CPSO discontinued its methadone policy, program standards, and guidelines in March 2021, these continue to inform the practices of Ontario prescribers who were expected to adhere to the guidelines as a standard of practice against which they would be explicitly assessed.

Mots clés

Clinical guidance
Policy/Regulatory
About prescribers
Illegal drugs
Substitution/OAT
Carries/take-home doses